Zimmerli Werner, Moser Claus
Basel University Medical Clinic, Kantonsspital, Liestal, Switzerland.
FEMS Immunol Med Microbiol. 2012 Jul;65(2):158-68. doi: 10.1111/j.1574-695X.2012.00938.x. Epub 2012 Mar 15.
Implant-associated infection is caused by surface-adhering bacteria persisting as biofilm. Periprosthetic joint infection is difficult to diagnose and treat. The high susceptibility of implanted devices to infection is because of a locally acquired host defense defect, and persistence is mainly because of the rapid formation of a biofilm resistant to host defense and antimicrobial agents. Successful treatment of periprosthetic joint infection requires the optimal surgical procedure combined with long-term antimicrobial therapy directed against surface-adhering microorganisms. Surgical treatment according to an algorithm has been validated in several observational studies. The role of rifampin against device-associated staphylococcal infection has been evaluated in an animal model, in observational studies and in a controlled trial. Given the limited efficacy of traditional antibiotics in implant-associated infections, novel strategies such as coating of the device, vaccination against biofilms, and quorum-sensing inhibitors are promising future options for prevention and treatment.
植入物相关感染是由作为生物膜持续存在的表面粘附细菌引起的。人工关节周围感染难以诊断和治疗。植入装置对感染的高易感性是由于局部获得性宿主防御缺陷,而持续性主要是由于对宿主防御和抗菌剂具有抗性的生物膜快速形成。成功治疗人工关节周围感染需要最佳的手术程序与针对表面粘附微生物的长期抗菌治疗相结合。根据算法进行的手术治疗已在多项观察性研究中得到验证。利福平在动物模型、观察性研究和对照试验中已对其抗装置相关葡萄球菌感染的作用进行了评估。鉴于传统抗生素在植入物相关感染中的疗效有限,诸如装置涂层、生物膜疫苗接种和群体感应抑制剂等新策略是预防和治疗未来有前景的选择。